Allianz Asset Management »

Apogee Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $313k 6.9k 45.30

More positions owned by Allianz Asset Management

Venture Global Com Cl A (VG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Ishares Tr Msci Emg Mkt Etf (EEM)
JPMorgan Chase & Co. (JPM)
Vici Pptys (VICI)
Cisco Systems (CSCO)

View all positions for Allianz Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics